Precision medicine holds great promise to improve outcomes in cancer, including
haematological malignancies. However, there are few biomarkers that influence choice of …

Despite improvements in therapy, multiple myeloma remains incurable. Chimeric antigen
receptor (CAR) T-cells have recently been demonstrated to be highly effective in the disease, …

Drug-induced autoimmunity (DIA) is an idiosyncratic adverse drug reaction. Although first
reported in the mid-1940s, the mechanisms underlying DIA remain unclear, and there is little …

Chimeric antigen receptor (CAR) T-cell therapy is a highly effective novel treatment in
haematological malignancies that has shown promise as a therapeutic option in multiple myeloma…

The global spread of multidrug-resistant enterobacteria warrants new strategies to combat
these pathogens. One possible approach is the reconsideration of “old” antimicrobials, which …

The glyceraldehyde 3-phosphate dehydogenase holoenzyme of Bacillus stearothermophilus
possesses precise 222 symmetry: in this respect it differs from the reported structure of the …

Genomic events associated with poor outcome in chronic myeloid leukemia (CML) are poorly
understood. We performed whole-exome sequencing, copy-number variation, and/or RNA …

Introduction: Multiple myeloma remains an incurable disease with a significant variation in
therapeutic response. Choice of treatment is largely determined by prior lines of therapy and …

A growing trend over the last few years is storage outsourcing, where the concept of third-party
data warehousing has become more popular. This trend prompts several interesting …

Autologous stem cell transplant (ASCT) is the current standard of care for eligible patients
with multiple myeloma (MM). The UK national trial CARDAMON investigated whether, …